Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=23143067&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Wnt agonist attenuates liver injury and improves survival after hepatic ischemia/reperfusion Kuncewitch M; Yang WL; Molmenti E; Nicastro J; Coppa GF; Wang PShock 2013[Jan]; 39 (1): 3-10The Wnt/beta-catenin signaling pathway is well characterized in stem cell biology and plays a critical role in liver development, regeneration, and homeostasis. We hypothesized that pharmacologic activation of Wnt signaling protects against hepatic ischemia/reperfusion (I/R) injury through its known proliferative and antiapoptotic properties. Sprague-Dawley rats underwent 70% hepatic ischemia by microvascular clamping of the hilum of the left and median lobes of the liver for 90 min, followed by reperfusion. Wnt agonist (2-amino-4-[3,4-(methylenedioxy)benzylamino]-6-(3-methoxyphenyl)pyrimidine, 5 mg/kg body weight) or vehicle (20% dimethyl sulfoxide in saline) in 0.5 mL was injected i.p. 1 h before ischemia or infused i.v. over 30 min right after ischemia. Blood and tissue samples from the pretreated groups were collected 24 h after reperfusion, and a survival study was performed. Hepatic expression of beta-catenin and its downstream target gene Axin2 were decreased after I/R, whereas Wnt agonist restored their expression to sham levels. Wnt agonist blunted I/R-induced elevations of aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase and significantly improved the microarchitecture of the liver. The cell proliferation determined by Ki67 immunostaining significantly increased with Wnt agonist treatment, and inflammatory cascades were dampened in Wnt agonist-treated animals, as demonstrated by attenuations in interleukin 6, myeloperoxidase, inducible nitric oxide synthase, and nitrotyrosine. Wnt agonist also significantly decreased the amount of apoptosis, as evidenced by decreases in both TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) staining as well as caspase 3 activity levels. Finally, the 10-day survival rate was increased from 27% in the vehicle group to 73% in the pretreated Wnt agonist group and 55% in the Wnt agonist postischemia treatment group. Thus, we propose that direct Wnt/beta-catenin stimulation may represent a novel therapeutic approach in the treatment of hepatic I/R.|Animals[MESH]|Apoptosis/drug effects[MESH]|Benzodioxoles/pharmacology/*therapeutic use[MESH]|Cell Proliferation/drug effects[MESH]|Disease Models, Animal[MESH]|Drug Evaluation, Preclinical/methods[MESH]|Hepatocytes/pathology[MESH]|Liver Diseases/pathology/physiopathology/*prevention & control[MESH]|Male[MESH]|Neutrophil Infiltration/drug effects[MESH]|Nitrosation/drug effects[MESH]|Pyrimidines/pharmacology/*therapeutic use[MESH]|Rats[MESH]|Rats, Sprague-Dawley[MESH]|Reperfusion Injury/pathology/physiopathology/*prevention & control[MESH]|Stress, Physiological/drug effects[MESH]|Survival Analysis[MESH]|Systemic Inflammatory Response Syndrome/prevention & control[MESH]|Up-Regulation/drug effects[MESH]|Wnt Proteins/*agonists/physiology[MESH]|Wnt Signaling Pathway/*drug effects/physiology[MESH]|beta Catenin/biosynthesis/genetics[MESH] |
